
GC25159
BMF-219
Also known as N-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-4-[[(3R)-3-(prop-2-enoylamino)piperidin-1-yl]methyl]pyridine-2-carboxamide
BMF-219 is a highly selective and irreversible inhibitor of menin which has shown very promising activity in in-vitro and in-vivo preclinical tumour models
ChemicalCAS2448172-22-1MW566.65FormulaC31H34N8O3
- CAS number
- 2448172-22-1
- Molecular weight
- 566.65
- Formula
- C31H34N8O3
- Solubility
- 50mg/mL in DMSO (Need ultrasonic)
- InChIKey
- CPRLHPSXWZTPMC-XMMPIXPASA-N
- Catalogue number
- GC25159
- Brand
- GLPBIO
Computed properties PubChem CID 154988914 · XLogP 2.8 · TPSA 128 Ų · H-bond donors 3
- XLogP
- 2.8
- TPSA
- 128 Ų
- H-bond donors
- 3
- H-bond acceptors
- 8
- Rotatable bonds
- 8
- Heavy atoms
- 42
SMILES C=CC(=O)N[C@@H]1CCCN(C1)CC2=CC(=NC=C2)C(=O)NC3=CC=C(C=C3)C4=CC5=C(N4)N=CN=C5N6CCOCC6
Computed descriptors from PubChem (CID 154988914), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il